Skip to main content
. 2024 Jan 11;13:1325144. doi: 10.3389/fcimb.2023.1325144

Figure 1.

Figure 1

Diagram of anti-tumor mechanisms of T. gondii. Infection of T. gondii can reverse the immunosuppressive state of tumor microenvironment and inhibit tumor angiogenesis, and its components profilin, ROP and GRA can also inhibit tumor progression through multiple immune and non-immune pathways. T. gondii, Toxoplasma gondii; PD-L1, programmed death ligand-1; CD4/8, cluster of differentiation 4/8; IgG, immunoglobulin G; TME, tumor microenvironment; DCs, dendritic cells; IL-12, interleukin-12; IFN-γ, interferon-γ; TNF-α, tumor necrosis factor-α; ROP, rhoptry; GRA, granule; NF-κB, nuclear factor kappa-B.